<html>
<head>PUBMED IDs for HA-8</head>
<body bgcolor='#C5F0F2'><h1>HA-8</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11148223/'>The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing.</a> January 10  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12135428/'>Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens.</a> July 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14648025/'>Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis.</a> December 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16571418/'>Multiplex genotyping of human minor histocompatibility antigens.</a> March 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16941596/'>Markedly different effects of hyaluronic acid and chondroitin sulfate-A on the differentiation of human articular chondrocytes in micromass and 3-D honeycomb rotation cultures.</a> August 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16941532/'>Observations on the presence of E domain variants of estrogen receptor-alpha in the breast tumors.</a> August 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16941528/'>Identification of estrogen receptor alpha variants in breast tumors: implications for predicting response to hormonal therapies.</a> August 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16941521/'>Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.</a> August 31  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17700601/'>Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT.</a> August 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18093280/'>Role of minor histocompatibility antigens in renal transplantation.</a> December 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18282267/'>Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing.</a> February 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18850018/'>Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.</a> October 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20026273/'>The cyclin-dependent kinase inhibitor PHA-848125 suppresses the in vitro growth of human melanomas sensitive or resistant to temozolomide, and shows synergistic effects in combination with this triazene compound.</a> July 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20197397/'>Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.</a> June 19  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20682657/'>Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22704958/'>Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125.</a> October 16  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23480177/'>Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.</a> July 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23480168/'>The role of redox signaling in epigenetics and cardiovascular disease.</a> October 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23480133/'>Association of intronic sequence variant in the gene encoding spleen tyrosine kinase with susceptibility to vascular dementia.</a> September 14  2013<br></body></html>
